As of 2026-02-04, the Fair Value of Rapt Therapeutics Inc (RAPT) is -19.06 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 57.75 USD, the upside of Rapt Therapeutics Inc is -133.01%.
With the market price of 57.75 USD and our fair value calculation, Rapt Therapeutics Inc (RAPT) is not a good investment. Investing in RAPT stocks now will result in a potential loss of 133.01%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -52.89 | -69.20 | -83.84 | -116.80 | -130.00 | -90.55 |
| YoY growth | -23.00% | -30.84% | -21.16% | -39.31% | -11.30% | -25.12% |
| Market Cap (mil) | 1,600.25 |
| P/E | |
| Forward P/E |
| EPS | -3.81 |
| Avg earnings growth rate | -25.12% |
| TTM earnings | -105.64 |